Homepage
Author:
Royalty Pharma plc
Posted Date:
March 30, 2026
Royalty Pharma Announces R&D Funding Collaboration for Chronic Immune-Mediated Diseases
Royalty Pharma plc
March 30, 2026
Royalty Pharma Appoints Lucas Glass as Head of Artificial Intelligence
Royalty Pharma plc
March 23, 2026
Royalty Pharma Announces Expansion of Leadership Team
Royalty Pharma plc
March 17, 2026
Royalty Pharma Appoints Kenneth Sun as Senior Vice President and Head of Asia to Expand Royalty Pharma’s Global Platform
Royalty Pharma plc
March 2, 2026
Royalty Pharma and Zymeworks Enter Into $250 Million Royalty-Backed Note Financing
Royalty Pharma plc
March 2, 2026
Royalty Pharma to Present at TD Cowen’s 46th Annual Health Care Conference
Royalty Pharma plc
February 26, 2026
Royalty Pharma Reports Q4 and Full Year 2025 Results
Royalty Pharma plc
February 11, 2026
